Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BIOX
BIOX logo

BIOX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.418
Open
0.397
VWAP
0.41
Vol
175.45K
Mkt Cap
25.97M
Low
0.390
Amount
71.10K
EV/EBITDA(TTM)
--
Total Shares
63.82M
EV
282.04M
EV/OCF(TTM)
--
P/S(TTM)
--
Bioceres Crop Solutions Corp. is a provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. Its segments include Seed and integrated products, Crop protection and Crop nutrition. Seed and integrated products segment focuses on the development and commercialization of seed technologies and products, including provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases, to increase their quality characteristics. Crop protection segment includes the development, production and marketing of adjuvants and a range of pest control molecules and biocontrol products. Crop nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers, including biofertilizers and micro-granulated fertilizers that optimize the productivity and yield of the crops.
Show More

Events Timeline

(ET)
2026-03-16
08:10:00
Bioceres CEO Discusses Financial Challenges and Restructuring Plans
select
2025-12-31 (ET)
2025-12-31
12:10:00
Bioceres Crop Solutions Appoints New CFO and Board Member
select
link
2025-09-23 (ET)
2025-09-23
07:05:26
Bioceres and Colorado Wheat Research Foundation Collaborate on HB4 Wheat Commercialization
select
2025-09-09 (ET)
2025-09-09
06:03:26
Bioceres announces Q4 revenue of $74.7M, falling short of consensus estimate of $110.08M
select
2025-08-22 (ET)
2025-08-22
07:41:24
Bioceres CFO Lopez Lecube Resigns
select
link

News

Newsfilter
9.5
03-16Newsfilter
Bioceres Reports Q2 Financial Results Amid Challenges
  • Financial Performance Pressure: Bioceres' Q2 financial results reveal revenue and working capital impacts due to sustained pressure on Argentine farmer economics, although the consolidated gross margin across its three business segments remains at 40%, demonstrating the resilience of its technology-driven product portfolio.
  • Asset Disposal and Impairment: A foreclosure auction for Pro Farm assets occurred on January 20, 2026, with a bid of $15 million against a carrying value of approximately $194 million, resulting in a $179 million impairment loss, highlighting significant financial challenges faced by the company.
  • Financing and Capital Structure: The company continues to face substantial doubt regarding its ability to secure additional financing, actively engaging with local Argentine financial institutions to refinance obligations while evaluating asset disposals and long-term financing options to restore market confidence and improve capital structure.
  • Board Governance Strengthening: Bioceres has strengthened its board by adding two new non-executive directors in Q2 of fiscal 2026, focusing on enhancing governance and independent oversight to navigate current challenges and ensure transparency with shareholders.
seekingalpha
2.0
03-13seekingalpha
Middle East Tensions Drive Fertilizer Stocks Rally
  • Market Reaction: Fertilizer stocks have rallied recently as escalating tensions in the Middle East raise concerns about nitrogen supply disruptions, with producers like CF Industries, Nutrien, and Mosaic seeing significant price increases reflecting market expectations of tighter availability.
  • Supply Chain Risks: Nearly half of global urea exports and about 30% of ammonia shipments originate from conflict-affected regions, raising supply concerns just as the Northern Hemisphere's spring planting season approaches, potentially impacting crop production.
  • Cost Advantage: Rising natural gas prices in Europe, a key feedstock for nitrogen fertilizer production, are widening the cost advantage for U.S. producers, enhancing their competitiveness in the global market.
  • Quant Rating Performance: Within the fertilizer sector, Intrepid Potash and Mosaic have received “Strong Buy” and “Hold” ratings respectively, with 5-day performances of 3.97% and 15.75%, indicating strong market confidence in these companies.
stocktwits
8.5
02-13stocktwits
Moolec Achieves Breakthrough Results and Stock Market Reaction
  • Increased Planting and Yields: Moolec cultivated approximately 1,100 acres of engineered safflower in the 2025 season, achieving an average yield of 2,200 pounds per acre, significantly up from 1,400 pounds in 2024, exceeding the company's expectations and demonstrating the effectiveness and potential of its agricultural technology.
  • GLA Concentration Validation: The company confirmed gamma-linolenic acid (GLA) concentrations of around 45% from its U.S. GLASO safflower platform, marking the operational feasibility of its plant-engineered molecular farming technology for commercial-scale production, laying the groundwork for sustainable revenue.
  • Nasdaq Listing Approval: On January 30, Moolec confirmed that the Nasdaq Hearings Panel approved its request for continued listing after the company regained compliance with minimum bid price requirements following a one-for-15 reverse stock split, boosting market confidence.
  • Positive Stock Market Reaction: Following the announcement of strong crushing results, Moolec's shares soared over 130% on Friday, with the stock gaining 241% year-to-date, reflecting strong investor optimism regarding its future growth prospects.
Benzinga
6.0
01-02Benzinga
BTIG Raises Hudson Pacific Price Target to $26
  • Target Price Increase: BTIG raised Hudson Pacific Properties' price target from $4.75 to $26, with analyst Thomas Catherwood maintaining a Buy rating, indicating strong confidence in the company's future growth prospects.
  • Market Performance: Hudson Pacific shares closed at $10.83 on Wednesday, and despite the significant target price increase, the current stock price remains below the target, suggesting a market undervaluation of its potential.
  • NRx Pharmaceuticals Target Adjustment: Ascendiant Capital increased the price target for NRx Pharmaceuticals from $47 to $48, with analyst Edward Woo maintaining a Buy rating, reflecting optimism about the company's product outlook.
  • Ulta Beauty Target Upgrade: Argus Research raised Ulta Beauty's price target from $650 to $700, with analyst Deborah Ciervo maintaining a Buy rating, indicating positive expectations for its market performance.
Yahoo Finance
5.0
2025-12-31Yahoo Finance
Bioceres Appoints Ezequiel Simmermacher as CFO
  • Executive Change: Bioceres Crop Solutions announced the appointment of Ezequiel Simmermacher as CFO, aiming to strengthen the company's financial management and strategic planning to support future growth objectives.
  • Enhanced Financial Leadership: With over 15 years of experience in finance and operations management, Simmermacher is expected to leverage his extensive industry knowledge and leadership skills to drive further development in the agricultural technology sector.
  • Strategic Direction Shift: The new CFO's appointment signifies Bioceres' efforts to optimize its financial structure and enhance investor confidence, which could positively impact the company's future capital operations and market performance.
  • Market Reaction Anticipation: The market generally views this appointment positively, believing that the new CFO's professional background will help Bioceres maintain its competitive edge in the fiercely competitive agricultural technology market.
Benzinga
4.0
2025-11-14Benzinga
Canaccord Genuity Keeps Hold Rating on Bioceres Crop Solutions, Reduces Price Target to $2.25
  • Real-time Intelligence: Benzinga Pro offers traders the fastest news alerts to stay updated on market movements.

  • Exclusive Stories: The platform provides unique stories generated by Benzinga reporters, enhancing trading insights.

  • Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, sharing valuable market intelligence.

  • Market Winning Tool: Benzinga Pro is designed to help traders succeed in the markets by providing accurate and timely information.

Wall Street analysts forecast BIOX stock price to rise
1 Analyst Rating
Wall Street analysts forecast BIOX stock price to rise
0 Buy
1 Hold
0 Sell
Hold
Current: 0.000
sliders
Low
2.00
Averages
2.00
High
2.00
Current: 0.000
sliders
Low
2.00
Averages
2.00
High
2.00
Canaccord
Austin Moeller
Hold
downgrade
$2
AI Analysis
2026-01-02
Reason
Canaccord
Austin Moeller
Price Target
$2
AI Analysis
2026-01-02
downgrade
Hold
Reason
Canaccord analyst Austin Moeller lowered the firm's price target on Bioceres to $2 from $2.25 and keeps a Hold rating on the shares. On December 18, New York's Supreme Court ruled against Bioceres in ongoing litigation with the company's creditors, the analyst tells investors in a research note. The firm says that with the judge's non-final verdict determined, a credit sale process of Bioceres' Pro Farm assets will likely now ensue. It believes the process could be damaging to the company's operations.
Canaccord
Hold
downgrade
2025-11-14
Reason
Canaccord
Price Target
2025-11-14
downgrade
Hold
Reason
Canaccord lowered the firm's price target on Bioceres to $2.25 from $2.50 and keeps a Hold rating on the shares. The firm reported lower Q1 revenues and adjusted EBITDA. The company has executed well on management's previously stated business priorities, including efforts to improve the business's margin profile, reduce operating expenses and better manage WC. Management cited expectations for the sustained unwinding of the seed business to temporarily lower upfront revenue recognition for the next two quarters in the segment.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BIOX
Unlock Now

Valuation Metrics

The current forward P/E ratio for Bioceres Crop Solutions Corp (BIOX.O) is 0.00, compared to its 5-year average forward P/E of 23.94. For a more detailed relative valuation and DCF analysis to assess Bioceres Crop Solutions Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
23.94
Current PE
0.00
Overvalued PE
37.87
Undervalued PE
10.01

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
10.20
Current EV/EBITDA
6.82
Overvalued EV/EBITDA
12.20
Undervalued EV/EBITDA
8.20

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.42
Current PS
0.26
Overvalued PS
2.00
Undervalued PS
0.84

Financials

AI Analysis
Annual
Quarterly

Whales Holding BIOX

F
Fourth Sail Capital LP
Holding
BIOX
-5.55%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Bioceres Crop Solutions Corp (BIOX) stock price today?

The current price of BIOX is 0.407 USD — it has increased 4.09

What is Bioceres Crop Solutions Corp (BIOX)'s business?

Bioceres Crop Solutions Corp. is a provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality. Its segments include Seed and integrated products, Crop protection and Crop nutrition. Seed and integrated products segment focuses on the development and commercialization of seed technologies and products, including provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases, to increase their quality characteristics. Crop protection segment includes the development, production and marketing of adjuvants and a range of pest control molecules and biocontrol products. Crop nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers, including biofertilizers and micro-granulated fertilizers that optimize the productivity and yield of the crops.

What is the price predicton of BIOX Stock?

Wall Street analysts forecast BIOX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BIOX is2.00 USD with a low forecast of 2.00 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Bioceres Crop Solutions Corp (BIOX)'s revenue for the last quarter?

Bioceres Crop Solutions Corp revenue for the last quarter amounts to 73.67M USD, decreased -25.49

What is Bioceres Crop Solutions Corp (BIOX)'s earnings per share (EPS) for the last quarter?

Bioceres Crop Solutions Corp. EPS for the last quarter amounts to -2.88 USD, decreased

How many employees does Bioceres Crop Solutions Corp (BIOX). have?

Bioceres Crop Solutions Corp (BIOX) has 751 emplpoyees as of March 31 2026.

What is Bioceres Crop Solutions Corp (BIOX) market cap?

Today BIOX has the market capitalization of 25.97M USD.